Paper Details

  1. Home
  2. Paper Details

Therapy of chronic lymphocytic leukemia patients. Results from the French cooperative trials. French Cooperative Group on Chronic Lymphocytic Leukemia.

Author:

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

A review of clinical trials for chronic lymphocytic leukemia found that CHOP chemotherapy was more effective than COP in stage C patients and intermittent chlorambucil-prednisone in stage B patients. Daily indefinite chlorambucil was associated with a negative impact on survival.
Paper Details　
Original Abstract of the Article :
This paper summarizes results from clinical trials in Chronic Lymphocytic Leukemia with a special emphasis on our protocols, CLL 80 and CLL 85, both based on the (A, B, C) staging. The third interim analysis of the CLL 80 protocol (973 patients, 287 deaths) confirmed, in stage C patients, the effect...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/3065741

データ提供：米国国立医学図書館（NLM）

Chronic Lymphocytic Leukemia: A Study of Treatment Options

Chronic Lymphocytic Leukemia (CLL) is a complex disease, and finding the right treatment is like navigating a vast, intricate labyrinth. This study explores the effectiveness of various treatment regimens for CLL, including the CHOP regimen (cyclophosphamide, doxorubicin, vincristine, prednisone) and the COP regimen (cyclophosphamide, vincristine, prednisone). The researchers conducted clinical trials, meticulously exploring different paths through the labyrinth, seeking the best treatment for patients with CLL.

The Search for Effective Treatment

The study compared the CHOP and COP regimens with other treatments, such as chlorambucil and no treatment at all. It found that the CHOP regimen was effective for patients in stage C, while the COP regimen did not show a benefit compared to chlorambucil for patients in stage B. The researchers also observed a toxic effect on survival from a daily indefinite course of chlorambucil compared to no treatment for stage A patients. This study provides valuable insights into the complex landscape of CLL treatment.

Navigating the Labyrinth of Treatment

The findings of this study can help patients and their doctors navigate the labyrinth of CLL treatment, making informed decisions about the most appropriate treatment regimen for their individual needs. It's like having a compass and a map to guide the way through a complex and potentially challenging terrain.

Dr. Camel's Conclusion

This study provides a valuable roadmap for the treatment of CLL, outlining the effectiveness and potential drawbacks of different treatment approaches. The researchers have done a great job of exploring the labyrinth of CLL treatment, providing valuable insights for patients and their doctors.

Date :
  1. Date Completed 1989-03-16
  2. Date Revised 2007-11-15
Further Info :

Pubmed ID

3065741

DOI: Digital Object Identifier

3065741

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.